Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ROLE OF HYPERTENSION AND SUPRAVENTRICULAR ARRHYTHMIAS IN COGNITIVE IMPAIRMENTS: THE CURRENT PROBLEM STATE

https://doi.org/10.20996/1819-6446-2013-9-5-519-524

Full Text:

Abstract

The causes of cognitive impairments (CI) in patients with arterial hypertension and supraventricular arrhythmias and CI prevalence rate in these patients are presented in details.

About the Authors

N. N. Kriukov
Samara State Medical University, Samara
Russian Federation


E. V. Portnova
Samara State Medical University, Samara Regional Clinical Cardiology Center, Samara
Russian Federation


References

1. National guidelines for the diagnosis and treatment of hypertension (fourth revision). Systemic hypertension 2010; (3): 5-26. Russian (Национальные рекомендации по диагностике и лечению артериальной гипертензии (четвертый пересмотр). Системные гипертензии 2010;(3):5-26).

2. Abbott R.D., Savage D.D., McNamara P.M. Coronary heart disease and atrial fibrillation: The Framingham Study, AM Heart J 1983;106:389-396.

3. Alonso A., Mosley T. H, Gottesman R. F., et all. Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry 2009;80:1194-1201.

4. Oganov RG, Timofeeva TN, Koltunov IE, et al. Epidemiology of hypertension in Russia. The results of the monitoring of the Federal 2003-2010. Cardiovascular Therapy and Prevention 2011;1:9-13. Russian (Оганов Р.Г., Тимофеева Т.Н., Колтунов И.Е. и соавт. Эпидемиология артериальной гипертонии в России. Результаты Федерального мониторинга 2003-2010г. Кардиоваскулярная Терапия и Профилактика 2011;1:9-13).

5. Cmakotina S.A., Barbarash O.L. On the timing of medication use in patients with hypertension. Cardiovascular Therapy and Prevention 2008; 7 (8): 344-345. Russian (Cмакотина С.А., Барбараш О.Л. К вопросу о сроках назначения медикаментозной терапии у больных гипертонической болезнью. Кардиоваскулярная Терапия и Профилактика 2008;7 (8):344-345).

6. Fuster V, Rydn LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation – executive summary. Circulation 2006; 114:700-52.

7. National guidelines for the diagnosis and treatment of atrial fibrillation. Rational Pharmacother Card 2011; (4) suppl: 1-80. Russian (Национальные рекомендации по диагностике и лечению фибрилляции предсердий. Рациональная Фармакотерапия в Кардиологии 2011; (4) приложение: 1-80).

8. Chazova I.E., Ratova L.G. Combination therapy of hypertension Moscow: Media Medika; 2007. Russian (Чазова И.Е., Ратова Л.Г. Комбинированная терапия артериальной гипертонии. М.: Медиа Медика, 2007).

9. Oganov R.G., Maslennikova G.Ja. Strategies for the prevention of cardiovascular diseases in the Russian Federation. Clinical Medicine 2012; (3): 4-9. Russian (Оганов Р.Г., Масленникова Г.Я. Стратегии профилактики сердечно-сосудистых заболеваний в Российской Федерации. Клиническая Медицина 2012; (3): 4-9).

10. Goette A., Honeycutt C., Langberg J. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94(11): 2968-2974.

11. Poteshkina N.G., Dzhanashija P.H. Structural and functional remodeling of the myocardium and prediction of arrhythmias in patients with arterial hypertension. Arterial Hypertension 2005;11(4):10-18. Russian (Потешкина Н.Г., Джанашия П.Х. Структурно-функциональное ремоделирование миокарда и прогнозирование аритмий у больных артериальной гипертонией. Артериальная Гипертензия 2005;11(4):10-18).

12. Naumov D.V., Ahmedov V.A., Dolgih V.T. et al. Current views on the tactics of the management of patients with atrial fibrillation. Vrach 2008;2:65-66. Russian (Наумов Д.В., Ахмедов В.А., Долгих В.Т. и др. Современные взгляды на тактику ведения пациентов с фибрилляцией предсердий. Врач 2008;2:65-66).

13. Milan A, Caserta MA, Dematteis A et al. Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients. Hum Hypertens 2009; 23(11):743-50.

14. Celujko V.I., Dmitriev S.Ju. The role of interstitial fibrosis as a predictor of atrial fibrillation. Medical Emergency Conditions 2007;3(10):124-126. Russian (Целуйко В.И., Дмитриев С.Ю. Роль интерстициального фиброза как предиктора возникновения фибрилляции предсердий. Медицина Неотложных Состояний 2007;3(10):124-126).

15. Schrander J, Luders S, Kulschewski A, et al. Morbidity and mortality after stroke, eprosaran compared with netrendipine for seondary prevention (MOSES study). Stroke 2005; 36: 1218-26

16. Schaller B. Extracranial-intracranial bypass to reduce the risk of ischemic stroke in intracranial aneurysms of the anterior cerebral circulation: a systematic review. J Stroke Cerebrovasc Dis 2008;17:287-98.

17. Kotova O.V., Akarachkova E.S. Chronic cerebral ischemia: pathogenetic mechanisms and treatment guidelines. Farmateka 2010;(8):57-61. Russian (Котова О.В., Акарачкова Е.С. Хроническая ишемия головного мозга: патогенетические механизмы и принципы лечения. Фарматека 2010;(8):57-61).

18. Smith FB,Lee AJ, Fowkes FGR, et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997;17:3321-25

19. Spencer CGC, Gurney D, Blann AD, et al. Von Willebrand factor, soluble P:selectin, and target organ damage in hypertension. A substudy of the Anglo:Scandinavian Cardiac Outcomes Trial (ASCOT) . Hypertension 2002; 40: 61-66

20. Vermeer SE, Hollander M, Dijk EJ et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population the Rotterdam Scan Study. Stroke 2003; 34: 1126-1129.

21. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke. Circulation 2006; 113: 873-923

22. Makolkin VI, Podzolkov VI, Pavlov VI, et al. Microcirculation in hypertension. Kardiologiia 2003; (5): 60-67. Russian (Маколкин В.И., Подзолков В.И., Павлов В.И. и соавт. Состояние микроциркуляции при гипертонической болезни. Кардиология 2003; (5):60-67).

23. Vereshhagin NV, Morgunov VA, Gulevskaja TS. The pathology of the brain in atherosclerosis and hypertension. Moscow: Meditsina; 1997. Russian (Верещагин Н.В., Моргунов В.А., Гулевская Т.С. Патология головного мозга при атеросклерозе и артериальной гипертонии. М.: Медицина; 1997).

24. Kugoev AI, Borisenko VV, Sharypova TN. Radionuclide neuroimaging. Medical Aid 2000; (3): 37-9. Russian (Кугоев А. И., Борисенко В. В, Шарыпова Т. Н. Радионуклидные методы нейровизуализации. Медицинская Помощь 2000; (3): 37-9).

25. Mitchell GF, Parise H, Benjamin EJ, еt al. Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women. The Framingham Heart Study. Hypertension 2004; 43: 1239-1243

26. Friberg J, Scharling H, Gadsboll N, et al. Sex-specifi cincrease in the prevalence of atrial fi brillation (The Copenhagen City Heart Study). American Journal of Cardiology 2003; 92(12):1419-23.

27. Truelsen T, Nielsen N, Boysen G, et al. Self reported stress and risk of stroke: The Copenhagen City Heart Study Stroke. Circulation 2003; 34(4): 856-862.

28. Kadnikova JuV, Shutemova EA, Maslennikova OA, et al. Daily blood pressure in elderly patients with borderline hypertension. Kardiolog 2005;(6):32-36. Russian (Кадникова Ю.В., Шутемова Е.А., Масленникова О.А. и др. Суточный профиль артериального давления у пожилых больных с пограничной артериальной гипертонией. Кардиолог 2005;(6):32-36).

29. Оhkubo T, Imai Y, Tsuji I, et al. Relation between nocturnal decline in blood pressure and mortality.The Ohasama study. Am J Hypertens 1997; 10: 1201-07.

30. Smakotina SA, Trubnikova OA, Barbarash OL. The effect of metoprolol tartrate on blood pressure and cognitive function in young to middle aged patients with essential hypertension. Rational Pharmacother Card 2008;(1):56-61. Russian (Смакотина С.А., Трубникова О.А., Барбараш О.Л. Влияние метопролола тартрата на артериальное давление и когнитивные функции у пациентов молодого и среднего возраста c гипертонической болезнью. Рациональная Фармакотерапия в Кардиологии 2008;(1):56-61.

31. Kobalava ZhD, Tolkacheva VI, Kotovskaja JuV. Cerebrovascular complications of hypertension. Qual- ity of life. Medicine 2005;(3):17-21.Russian (Кобалава Ж.Д., Толкачева В.И., Котовская Ю.В. Цереброваскулярные осложнения артериальной гипертонии. Качество жизни. Медицина 2005;(3):17-21).

32. Fagard RH, Cornelissen A. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007;25:2193-98.

33. Norrving B. Lacunar infarcts: no black holes in the brain are benign. Practical Neurology 2008; 8: 222-8.

34. Bolotova TA, Anufriev PL. Criteria for diagnosis of ischemic strokes of different pathogenic subtypes in patients with atherosclerosis and hypertension. Annals of Clinical and Experimental Neurology 2009;(4):4-10. Russian (Болотова Т.А., Ануфриев П.Л. Критерии диагностики ишемических инсультов разных патогенетических подтипов у больных с атеросклерозом и артериальной гипертонией. Анналы Клинической и Экспериментальной Неврологии 2009; (4): 4-10).

35. Shmyrev VI, Sokolova LP. Features of brain metabolism in mild and moderate (dodementnyh) cog- nitive disorders of various origins. Medical Science and Education of the Urals 2011;(2):64-68 Russian (Шмырев В.И., Соколова Л.П. Особенности метаболизма мозга при легких и умеренных (додементных) когнитивных расстройствах различного генеза. Медицинская Наука и Образование Урала 2011;(2):64-68).

36. Kearney-Schwart A, Rossignol P, Bracard S, et al. Vascular structure and Function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40:1229-1236.

37. Henskens LH, van Oostenbrugge RJ, Kroon AA, et al. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. J Hypertens 2009;27:846-853.

38. Bernick C, Katz R, Smith N.L et al. Cardiovascular Health Study Collaborative Research Group. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 2005; 65(9): 1388-94.

39. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137: 263-72.

40. Brott TG, Hobson RW. CREST Investigators. Stenting versus endarterectomy for treatment of carotidartery stenosis. N Engl J Med 2010;362: 11-23.

41. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary.Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007;28:2803-17.

42. Kario K, Matsuo T, Kobayashi H, et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension 1996; 27: 130-135.

43. Ezekowitz MD, James KE, Nazarian SM, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 1995; 92: 2178-2182.

44. Nabauer M, Gerth A, Limbourg T, et al . The Registry of the German Competence NETwork on atrial fibrillation: patient characteristics and initial management. Europace 2009; 11:423-434.

45. Vereshhagin N.V., Varakin JuJa. Registers stroke in Russia: results and methodological aspects of the problem. Journal of Neurology and Psychiatry n.a. SS Korsakov 2001; (1) suppl:34-40. Russian (Ве- рещагин Н.В., Варакин Ю.Я. Регистры инсульта в России: результаты и методологические аспекты проблемы. Журнал Неврологии и Психиатрии им. С.С.Корсакова 2001;(1) приложение :34-40).

46. Odinak MM, Emelin AJu, Pozdnjakov AV, et al. Functional neuroimaging in the diagnosis of dementia. Bulletin of the Russian Military - Medical Academy 2006;1(15):101-110 Russian (Одинак М.М., Емелин А.Ю, Поздняков А.В.и соавт. Функциональная нейровизуализация в диагностике деменций. Вестник Российской Военно-Медицинской Академии 2006;1(15):101-10).

47. Emelin AJu. Structural neuroimaging in the differential diagnosis of vascular cognitive impairment. Bulletin of the Russian Military - Medical Academy 2010;3(31):97-102. Russian (Емелин А.Ю. Структурная нейровизуализация в дифференциальной диагностике сосудистых когнитивных нарушений. Вестник Российской Военно-Медицинской Академии 2010; 3 (31): 97-102).

48. Markin S.P. Cognitive impairment in medical practice. Voronezh: VGMA; 2008. Russian (Маркин С.П. Нарушение когнитивных функций во врачебной практике. Методическое пособие. Воронеж: ВГМА; 2008).

49. Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40: 1229-1236.

50. Manciaa G, Laurentb S, Agabiti-Roseic E, et. Reappraisal of European guidelines of hypertension man- agement: a European Society of Hypertension Task Forse document. J Hypertension 2009; 27: 2121-2158.

51. Skood, B. Lernfelt, S. Landahl et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145.

52. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure level and latelife cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274 (23): 1846-51.

53. Syst-Eur study. Systolic hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162(18): 661-663.

54. Ruitenberg A, Skoog I, Ott A, et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001; 12 (1) 33-9.

55. Elias PK, Elias MF, Robbms MA, et al. Blood Pressure-Related Cognitive Decline Does Age Make a Difference. Hypertension 2004; 44: 631.

56. Park H, Hildreth A, Thomson R, O’Connell J. Non-valvular atrial fibrillation and cognitive decline: a lon- gitudinal cohort study. Age Ageing 2007; 36 (2): 157-163.

57. Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? .Minerva Cardioangiol 2009;57 (2):143-150

58. Pullicino PM, Wadley VG, McClure LA, et al. Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. J Card Fail 2008;14 (4):290-295.

59. Ravaglia G, Forti P, Maioli F, et.al. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 2006; 21 (1): 51-58.

60. Knecht S,Oelschlager C, Duning T, et al. Atrial fibrillation in stroke-free patiens is associated with memory impairment and hippocampal atrophy. Eur Heart J 2008;29: 2125-2132.

61. Nabauer M, Gerth A, Limbourg T, et al . The Registry of the German Competence NETwork on atrial fibrillation: patient characteristics and initial management. Europace 2009; 11:423-434.

62. Zaharov VV. National Research Programme of Epidemiology and treatment of cognitive disorders in the elderly ("Prometheus"). Journal of Neurology 2006;(11):27—32. Russian (Захаров В.В. Всероссийская программа исследований эпидемиологии и терапии когнитивных расстройств в пожилом возрасте («Прометей»). Неврологический Журнал 2006;(11):27—32).


For citation:


Kriukov N.N., Portnova E.V. ROLE OF HYPERTENSION AND SUPRAVENTRICULAR ARRHYTHMIAS IN COGNITIVE IMPAIRMENTS: THE CURRENT PROBLEM STATE. Rational Pharmacotherapy in Cardiology. 2013;9(5):519-524. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-5-519-524

Views: 526


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)